Patient Access Scheme
Companies can submit Patient Access Schemes (PAS) to improve the cost effectiveness of a medicine.
The Patient Access Scheme Assessment Group (PASAG) reviews and advises NHSScotland on the feasibility of proposed schemes for implementation. It operates separately from SMC to maintain the integrity of the assessment process.
NICE Multiple Technology Appraisals
From 1 October 2017, National Institute for Health and Care Excellence (NICE) Multiple Technology Appraisals (MTAs) will no longer be assessed by Healthcare Improvement Scotland (HIS) for applicability to NHSScotland. Any new medicines that are going through the NICE MTA process and have not been assessed by the Scottish Medicines Consortium (SMC) will require a submission to SMC. This change has no bearing on MTAs that have been endorsed by HIS to date; the advice from these MTAs will continue to apply.